Litcius/Paper detail

Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial

Harpreet S. Bajaj, Hertzel C. Gerstein, Rao Ps, Jan Basile, Helen M. Colhoun, Ignacio Conget, William C. Cushman, Gilles R. Dagenais, Edward Franek, M Hanefeld, Mátyás Keltai, Mark Lakshmanan, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Valdis Pīrāgs, Nana Pogosova, Jeffrey L. Probstfield, Peter Raubenheimer, Lars Rydén, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Denis Xavier

2021The Lancet Diabetes & Endocrinology51 citationsDOI

Topics & Concepts

DulaglutidePlaceboMedicineType 2 diabetesExploratory analysisErectile functionInternal medicinePhysical therapyDiabetes mellitusErectile dysfunctionEndocrinologyAlternative medicineExenatideComputer scienceData sciencePathologySexual function and dysfunction studiesHormonal and reproductive studiesDiabetes Treatment and Management
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial | Litcius